Irbesartan Tablet
Product Images NDC 70518-1543

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 70518-1543). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Irbesartan 300mg 70518 1543 01

This is a description of Irbesartan Tablets, with a dosage strength of 300 mg and a quantity of 90 tablets. The tablets are oval and white in color. The packaging includes information such as the NDC number, expiration date, manufacturer details, and instructions to store the medication at specific temperatures. The usual dosage information is provided on an insert. Additionally, it is repackaged by RemedyRepack Inc. in Indiana, PA.*

FDA Label Image

Structure (Spl Image1 Structure)

FDA Label Image

Figure 1 (Spl Image2 Figure1)

FDA Label Image

Figure 2 (Spl Image3 Figure2)

FDA Label Image

Figure 3 (Spl Image4 Figure3)

This document provides information about a cumulative event rates study comparing two medications, besartan and Amlodpine, with a placebo. The study results are presented in a table with data on Relative Risk (RR) for besartan versus placebo and besartan versus Amlodpine. The table also includes percentages for different time points of follow-up.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.